Saxenda - supply shortage
Shortage resolved
liraglutide
ShortageHuman
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
Shortage information
An increase in demand for Saxenda led to intermittent supply shortages in 2023 and 2024. The shortage affecting Saxenda has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Saxenda
- Supply shortage status
- Shortage resolved
- International non-proprietary name (INN) or common name
- liraglutide
- Therapeutic area (MESH)
- Obesity
- Overweight
- Pharmaceutical forms affected
- Solution for injection in pre-filled pen
- Strengths affected
- 6 mg/ml
Key dates
- First published
- Last updated